Editorial commentary: Searching for the sweet spot of cardioprotection in cancer treatment related cardiotoxicity: Who will benefit?

Trends Cardiovasc Med. 2020 Jan;30(1):29-31. doi: 10.1016/j.tcm.2019.02.003. Epub 2019 Feb 15.

Authors

Richard K Cheng¹, Eric H Yang²

Affiliations

¹ UW Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA, United States. Electronic address: rkcheng@uw.edu.
² UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.

PMID: 30797696
DOI: 10.1016/j.tcm.2019.02.003

No abstract available

Keywords: Breast cancer; Cardio-oncology; Cardioprotection; Cardiotoxicity.

Publication types

Editorial
Comment

MeSH terms

Breast Neoplasms*
Cardiotoxicity
Cardiovascular Diseases*
Humans
Neoplasms*